Michelle Bhatt

Michelle Bhatt investigates the intersection of thymic tumors and autoimmune paraneoplastic syndromes, particularly myasthenia gravis associated with thymoma. Her research has characterized mechanisms by which thymic tumors disrupt central tolerance and trigger autoimmunity. She has developed biomarker panels to predict autoimmune complications and guide treatment decisions in thymoma patients. Her work has improved the clinical management of patients dealing simultaneously with thymic malignancy and paraneoplastic conditions.